Let-7b inhibits human cancer phenotype by targeting cytochrome P450 epoxygenase 2J2.
about
The effects of microRNA on the absorption, distribution, metabolism and excretion of drugsMiRNAs and miRNA Polymorphisms Modify Drug ResponseCytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance.Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancerRBMMMDA: predicting multiple types of disease-microRNA associations.MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective TherapyCYP2J2 overexpression increases EETs and protects against angiotensin II-induced abdominal aortic aneurysm in mice.High-throughput profiling of alpha interferon- and interleukin-28B-regulated microRNAs and identification of let-7s with anti-hepatitis C virus activity by targeting IGF2BP1.Regulation of multidrug resistance by microRNAs in anti-cancer therapyHyperhomocysteinemia results from and promotes hepatocellular carcinoma via CYP450 metabolism by CYP2J2 DNA methylationRole of microRNAs in the regulation of drug metabolism and disposition genes in diabetes and liver disease.Friend or foe: the role of microRNA in chemotherapy resistance.Mechanism analysis of colorectal cancer according to the microRNA expression profile.microRNAs: An Emerging Paradigm in Lung Cancer Chemoresistance.Opposing activities of oncogenic MIR17HG and tumor suppressive MIR100HG clusters and their gene targets regulate replicative senescence in human adult stem cells.CYP2J2 - regulation, function and polymorphism.Exosomes Derived from MicroRNA-584 Transfected Mesenchymal Stem Cells: Novel Alternative Therapeutic Vehicles for Cancer Therapy.Let-7b contributes to hepatocellular cancer progression through Wnt/β-catenin signaling
P2860
Q26822987-64597365-8B24-4ECB-A4DE-A90F8A7AB44BQ28079075-45905D2F-A92C-480A-B1C6-B9A0A5A9BE35Q34358307-43FB0241-3CED-4636-8128-82FA70E3C806Q34584945-1786714F-A8EF-4D15-86BB-B1F79E18C274Q36034189-CB8A1124-19B4-42A0-BDCD-B7E4B5D7FAC9Q36618667-169894A8-CAC1-457F-802A-F1FBE7B1C00FQ36754838-982D8872-DD75-4EAC-BF27-CEB76E7DCF1CQ37123557-752B1B1E-30F9-465C-A1E4-987FFBF85A14Q37587311-152CE943-D541-4117-B1E3-0F0E1FE0F12EQ37716553-59B2D53D-9B00-4E95-AEB5-7FC1872476BBQ38097092-BB5DAF86-B56D-4745-88CA-214EC946FB6EQ38102553-405F970B-62A0-45CD-BBFA-9EA7B09A69E6Q38442211-E40ACE3A-6E78-4EC1-B79D-C4B55483D890Q38638204-8430BA7A-F38C-4BD0-870A-4F142431931CQ42219946-2BA75D13-49C8-4207-B7A7-58761A4C85FEQ51709663-7C578D93-5B27-4F62-BEEB-080D7E9F9DDFQ55456702-C5BC98EC-0E15-4E53-9251-02BEFCA94066Q57178941-DF8D03BC-0EB5-4862-AD9D-CE2C3729C464
P2860
Let-7b inhibits human cancer phenotype by targeting cytochrome P450 epoxygenase 2J2.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Let-7b inhibits human cancer phenotype by targeting cytochrome P450 epoxygenase 2J2.
@ast
Let-7b inhibits human cancer phenotype by targeting cytochrome P450 epoxygenase 2J2.
@en
Let-7b inhibits human cancer phenotype by targeting cytochrome P450 epoxygenase 2J2.
@nl
type
label
Let-7b inhibits human cancer phenotype by targeting cytochrome P450 epoxygenase 2J2.
@ast
Let-7b inhibits human cancer phenotype by targeting cytochrome P450 epoxygenase 2J2.
@en
Let-7b inhibits human cancer phenotype by targeting cytochrome P450 epoxygenase 2J2.
@nl
prefLabel
Let-7b inhibits human cancer phenotype by targeting cytochrome P450 epoxygenase 2J2.
@ast
Let-7b inhibits human cancer phenotype by targeting cytochrome P450 epoxygenase 2J2.
@en
Let-7b inhibits human cancer phenotype by targeting cytochrome P450 epoxygenase 2J2.
@nl
P2093
P2860
P1433
P1476
Let-7b inhibits human cancer phenotype by targeting cytochrome P450 epoxygenase 2J2.
@en
P2093
Dao Wen Wang
Fuqiong Chen
Jiarong Tang
Shenglan Yang
P2860
P304
P356
10.1371/JOURNAL.PONE.0039197
P407
P577
2012-06-25T00:00:00Z